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Abstract
Typical amyloid diseases such as Alzheimer’s and Parkinson’s were thought to exclusively result from de novo aggregation,
but recently it was shown that amyloids formed in one cell can cross-seed aggregation in other cells, following a prion-like
mechanism. Despite the large experimental effort devoted to understanding the phenomenon of prion transmissibility, it is
still poorly understood how this property is encoded in the primary sequence. In many cases, prion structural conversion is
driven by the presence of relatively large glutamine/asparagine (Q/N) enriched segments. Several studies suggest that it is
the amino acid composition of these regions rather than their specific sequence that accounts for their priogenicity.
However, our analysis indicates that it is instead the presence and potency of specific short amyloid-prone sequences that
occur within intrinsically disordered Q/N-rich regions that determine their prion behaviour, modulated by the structural and
compositional context. This provides a basis for the accurate identification and evaluation of prion candidate sequences in
proteomes in the context of a unified framework for amyloid formation and prion propagation.
Citation: Sabate R, Rousseau F, Schymkowitz J, Ventura S (2015) What Makes a Protein Sequence a Prion? PLoS Comput Biol 11(1): e1004013. doi:10.1371/journal.
pcbi.1004013
Editor: Jacquelyn S. Fetrow, Wake Forest University, United States of America
Received June 9, 2014; Accepted October 29, 2014; Published January 8, 2015
Copyright:  2015 Sabate et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its
Supporting Information files.
Funding: This work was supported in part by grants BFU2010-14901 from Ministerio de Ciencia e Innovacion (Spain), by grant 2014-SGR 938 from AGAUR
(Agencia de Gestio d’Ajuts Universitaris i de Recerca-Generalitat de Catalunya). The Switch Laboratory was supported by grants from VIB, University of Leuven, the
Funds for Scientific Research Flanders (FWO), the Flanders Institute for Science and Technology (IWT) and the Federal Office for Scientific Affairs of Belgium
(Belspo), IUAP P7/16. RS is the beneficiary of a contract from the Ramo´n y Cajal Programme (RYC-2011-07987) from Ministerio de Ciencia e Innovacio´n. SV has
been granted an ICREA-ACADEMIA award (Institucio´ Catalana de Recerca I Estudis Avanc¸ats).
Competing Interests: The authors have declared that no competing interests exist.
* Email: rsabate@ub.edu (RS); salvador.ventura@uab.es (SV)
Introduction
Amyloid structures are associated with an increasing number
of human disorders [1]. Prions have been considered a
particular subclass of amyloids in which the aggregation process
self-perpetuates in vivo, thus becoming infectious. However,
increasing evidence suggests that in vivo protein cross-seeding
may in fact reach beyond the scope of relatively rare disorders
such as Kuru or Creutzfeld-Jacob Disease, to frequently
occurring neurodegenerative pathologies, including Alzheimer’s
and Parkinson’s diseases [2–4]. So far it seems that the similarity
only covers certain aspects of prion behaviour, causing Aguzzi
to coin the term ’prionoids’ [5]. A unifying aspect is certainly
the amyloid structure adopted by prions and prionoids alike and
which is thought to be behind in vivo seeded aggregation.
However, the critical features that allow a specific amyloido-
genic sequence to become prionogenic and thus infectious are
still not clear.
Fungal prions provide excellent model systems for the
understanding of amyloid formation and propagation [6]. An
increasing number of prion proteins are being identified in
yeast, the best-characterized being NEW1, RNQ1, SWI1,
SUP35 and URE2 proteins. Protein domains involved in prion
formation in all these polypeptides are highly enriched in
asparagine (N) and/or glutamine (Q) residues and often
correspond to intrinsically unstructured protein regions. Protein
domains displaying this sequence signature are over represented
in eukaryotic genomes relative to prokaryotes. Given their
potential involvement in pathogenic processes, the fact that
these sequences have not been suppressed by purifying selection
suggests that prion-like conformational conversion may have
evolved as a mechanism for regulating functionality in eukary-
otic proteins [7]. Recently, Lindquist’s group conducted a
genome-wide in silico survey to identify prionogenic proteins in
the S. cerevisiae proteome on the basis of their compositional
similarity to known prion forming domains (PFDs) using a
hidden Markov model. The prionogenic nature of the top 100
identified candidate PFDs was evaluated through experimental
investigations of four in vitro and in vivo prion characteristics
[8]. 29 of them, including the PFDs of previously known yeast
prions, showed one of the key features, namely switching
behaviour between a soluble and prion form in cells or strong
amyloid formation capability. Nevertheless, still 68% of the fully
characterized domains turned to be false-positives, even with
several of them displaying the highest composition similarity to
known PFDs. This dataset provides an outstanding benchmark
to decipher how prion transmissibility is encoded in polypeptide
sequence.
The sequence of a protein determines to a large extent its
amyloid propensity [9]. It has been argued, however, that two
distinct classes of amyloid polypeptides exist [10]. The first class
follows the by now classical short-stretch model [11–13], in
PLOS Computational Biology | www.ploscompbiol.org 1 January 2015 | Volume 11 | Issue 1 | e1004013
which self-assembly is thought to be nucleated specifically by
short sequences of high amyloid propensity, whereas in the
second class a large number of weak interactions between side-
chains in large, structurally disordered domains would constitute
the driving force for amyloid formation. According to this
classification, prionoid proteins like Aß, tau and a-synuclein
would belong to the first class, whereas the Q/N rich yeast
prions will fall in the second one. It has been suggested that this
mechanistic difference would explain why algorithms designed
to detect short and specific amyloid motifs in proteins [14]
usually fail to classify correctly Q/N rich prionic and non-
prionic sequences [15].
The WALTZ algorithm [16] (http://waltz.switchlab.org/)
uses a position-specific scoring matrix deduced from the
biophysical and structural analysis of the amyloid properties
of a large set of hexapeptides (S1 Fig.). A distinctive feature of
WALTZ is that most amino acids are predicted to display
differential amyloid propensities depending on their specific
position in the sequence. This is the case of Q and N residues,
which contribute positively or negatively to the amyloid
potential depending on their position (S1 Fig.). The edge
positions 1, 2 and 6 in the matrix display low selectivity,
whereas the core positions 3, 4 and 5 are highly restrictive.
Aromatic and hydrophobic residues remain most favored in
the core positions. However, certain polar residues, including
Q and N, can be accommodated or even be favorable in these
locations. The ability to consider position-specificities allows
WALTZ to specifically identify short sequences leading to
ordered amyloid aggregates, including those formed by Q/N
enriched SUP35 decapeptides [16]. Here we show that this
ability can be exploited to classify prionic and non-prionic
sequences providing an alternative description of the sequence
features that underlie prion formation. In our model, priono-
genic behaviour requires the embedding of a relatively short
amyloid forming sequence in a flexible region enriched in the
typical polar amino acids Q and N. This alternative model of
prion behavior provides a unified framework for amyloid
formation and prion propagation.
Results
The relationship between amyloidogenicity and prion
propensity
Ross and Toombs have shown that the sequence of a short
eight-residue stretch of a variant of Sup35 PFD suffices to
determine the priogenicity of the complete protein, revealing that
the presence of hydrophobic residues, which are otherwise under-
represented in PFDs, highly increase the overall prion propensity
[17]. The presence of hydrophobic residues is recurrently observed
in amyloid sequences and, in fact, when we analysed the 62
sequence variants they tested in this short Sup35 region using
WALTZ (with default settings) we observed that 44.4% of prion-
promoting sequences were predicted as amyloidogenic, whereas
only 14.2% of non-prionic sequences were identified as such (S1
Table). This suggests that the enrichment in hydrophobic residues
in prion-promoting stretches acts by increasing their sequential
amyloid propensity and therefore that the presence of short and
specific amyloid sequences might be an important contributor to
the prionogenicity of a Q/N rich sequence, as previously proposed
[18,19]. Based on this hypothesis, we wondered if prediction of
amyloidogenicity might aid to discriminate prion from non-prions
in the protein dataset experimentally characterized by Alberti et
al. The authors of that study scored the domains from 0 to 10
according to their combined performance in four different assays
that include tests for both amyloid and prion forming ability. We
considered as non-prions those sequences scoring #2 and being
positive in one assay at maximum, meaning that they do not
exhibit amyloid and prion forming ability at the same time,
yielding a total of 39 sequences (Table 1). We considered as prions
those domains being positive in all four assays and scoring $9,
with a total of 12 sequences, including the known prions NEW1,
RNQ1, SWI1, SUP35 and URE2 proteins (Table 1).
The unique atomic-resolution structure of an infectious fibrillar
state to date corresponds to HET-s PFD of the fungus Podospora
anserina. In its fibrillar conformation, HET-s PFD forms a left-
handed b-solenoid, with each molecule forming two helical
windings [20]. The two repeating strand–turn–strand motifs
(b1–b2 and b3–b4) forming two turns of the solenoid contain 21
residues each. A distant homolog of the fungal HET-s prion in
Fusarium graminum adopts an analogous structure with strand–
turn–strand motifs of ,21 residues [21]. Although the HET-s
PFDs are not related to those found in yeast, this implies that a
length of 21 might suffice to form a transmissible b-fold.
Therefore, we used a 21 residues sliding window to analyse the
amyloid propensity of the complete PFD sequences in our dataset,
with sizes comprised between 60 and 385 residues, with WALTZ.
In addition, because Pro has been shown to act as a b-breaker
residue [22] that efficiently opposes b-aggregation [23,24] and
mutation of any residue in HET-s PFD b-strands to Pro abrogates
prion propagation [25], we defined that the 21 residues windows
cannot include Pro residues.
The WALTZ algorithm can be run using different levels of
stringency or custom defined thresholds. In a typical use, WALTZ
high stringency levels (.90%) are employed in order to identify
very short and potent segments able to nucleate amyloid formation
with high specificity. For example, the analysis of the 758 residue
long Tau protein renders a single prediction overlapping with the
experimentally validated hexapeptide 591-KVQIIN-596 [26–31].
However, the identification and scoring of these strong and short
protein stretches, usually flanked by highly soluble residues, does
not allow an accurate discrimination between prionic and non-
prionic Q/N rich sequences [15]. In the present approach, a
sequence is considered for further analysis as a putative PFD
Author Summary
Protein conformational disorders include several neurode-
generative diseases. These pathologies are initiated by
conformational changes in specific polypeptides that, in
many cases, result in their spontaneous self-assembly to
form toxic amyloids. Prions are a subclass of amyloids with
the ability to propagate in vivo, thus becoming infectious.
Previous work with yeast prions has provided tremendous
insight into prion propagation mechanism. These proteins
contain glutamine/asparagine (Q/N) enriched prion form-
ing domains (PFDs), which are both necessary and
sufficient for propagation. We found that these domains
include specific short amyloid-prone sequences, which are
likely able to trigger the amyloid conversion of the
complete prion protein. The amyloid potency of these
short segments suffices to discriminate with high accuracy
between Q/N rich domains with and without prion activity.
Our data suggest a model for prions where a classical
amyloid core is embedded in a sequence context that
reduces the amyloid nucleation potential, resulting in
sequences that are strongly dependent on seeding. This
model should allow the identification of prion-like proteins
in the human proteome and prediction of the deleterious
effects of genetic mutations occurring in these particular
proteins.
Prediction of Prion Proteins
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Table 1. Prediction of the prionic behaviour of putative Q/N rich yeast prions.
Gene Name pWALTZ Score P/NP(b) Gene Name pWALTZ Score P/NP(b)
MCM1 59.63 NP PUF2 73.07 P
NAB2 56.43 NP SWI1 75.43 P
TAF12 55.60 NP KSP1 75.97 P
YCK1 64.05 NP ASM4 75.73 P
MED2 65.49 NP URE2 73.66 P
AKL1 69.90 NP GLN3 74.36 P
PUF4 73.85 NP RNQ1 74.82 P
PCF11 64.29 NP NEW1 85.60 P
EPL1 68.82 NP NRP1 76.11 P
SNF2 67.91 NP LSM4 76.89 P
SCD6 67.03 NP YBL081W 76.78 P
YAK1 61.84 NP SUP35 73.99 P
CAF40 56.70 NP
NRD1 56.92 NP
PDC2 68.66 NP
RAT1 71.46 NP
SLA1 68.05 NP
SIN3 69.95 NP
UPC2 73.44 NP
TIF4632 71.64 NP
CLA4 53.86 NP
SKG3 68.47 NP
TIF4631 66.13 NP
SLT2 51.68 NP
AZF1 72.27 NP
CCR4 65.89 NP
NUP57 73.01 NP
SSD1 69.09 NP
VTS1 69.76 NP
PSP1 73.05 NP
YAP1802 64.13 NP
YMR124W 53.75 NP
ENT2 - NP
SKG6 - NP
YLR177W - NP
PIN3 - NP
WWM1 - NP
NAB3 - NP
HRR25 - NP
Prion recovery using the prion/non-prion (NP/P) classification of selected putative prions according to Alberti’s scale of prion activity. Sequences with pWALTZ score .
73.55 are considered prion-like. False positives and false negatives are underlined. Proteins devoid of any predicted amyloid core are shown in italics (SUP35, in plain
text, was not included in the test set to avoid overlap with the WALTZ training set).
(b)Prion/Non-Prion (P/NP) classification according to Alberti et. al. scale of prion propensity (Cell 137, 146–158). Sequences scoring #2 (1 positive assay as a maximum)
are considered non-prions (NP) while sequences scoring $9 (all four asays positives) are considered prions (P).
doi:10.1371/journal.pcbi.1004013.t001
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candidate only if at least in one of the sliding windows all the 21
residues display values higher than the a given threshold. SUP35
was excluded from the test set, since one tetra- and three hexa-
peptides belonging to its PFD sequence were part of the WALTZ
training set. We used receiver operating characteristic (ROC)
curves and evaluated the area under the curve (AUC) for each
particular WALTZ stringency level (between 0 and 100%) and
used the derived Youden’s index for each plot to identify the
threshold and the associated WALTZ score rendering the best
predictability. The best values were obtained using a threshold of
35%. Despite this amyloidogenicity value is very low, according to
the WALTZ scale, already seven of the non-prion proteins did not
exhibit any continuous 21 residues sequence stretch able to pass
the threshold. We used the rest of 32 non-prion domains and the
11 prion domains to elaborate the correspondent ROC plot which
displays a striking AUC of 0.99 (Fig. 1), employing a WALTZ
score cut off of 73.55% to discriminate between prion and non-
prion domains (Table 1) according to the associated Youden’s
index. With these parameters, the approach, which we call now as
pWALTZ, has a significance P value ,0.0001, a sensitivity of
90.9% and a specificity of 97.4%, with only one false positive
(PUF4) and one false negative (PUF2) among the 43 analysed
proteins (Table 1) and an overall accuracy of 95.3% (Fig. 1). All
the known bona fide yeast prions included in the test set (NEW1,
RNQ1, SWI1 and URE2) are correctly classified as positive hits.
The approach outperforms composition based algorithms like
PAPA (Fig. 1) [15], which displays a 86.0% overall accuracy in the
same dataset. As expected, SUP35 is also correctly classified as a
prion (Table 1). As shown in Fig. 2, prionic sequences display
clearly overall higher pWALTZ values than non-prionic ones. The
observed difference is significant, especially if we take into account
that we do not include in the comparison those sequences that
failed to past the soft 35% initial threshold. An example of the
scoring of prion and non-prion sequences is provided in the
Supplementary Material (S2 Fig.).
In a pioneering exercise, Ross and co-workers used PAPA to
design two synthetic PFD (s-PFDs) that function as prions in vivo
and three negative controls that fail to exhibit this phenotype, all
them sharing Q/N content with the Sup35 PFD [15]. pWALTZ
correctly classifies the prion activity of these s-PFDs and controls.
The score of synthetic PFD fit well with those of the PFD of
natural yeast prions (Table 2). Thus, the differential prionogenicity
of these artificial sequences correlates with the potency of their
identified amyloid cores, suggesting that their prion propensities
depend on their relative ability to form ordered assemblies
nucleated by relatively short stretches displaying specific sequential
properties and not in more diffuse and essentially sequence
independent protein features spread out over large domains, as
previously suggested [15].
The number of human proteins containing sequence stretches
resembling in composition to yeast PFDs account for ,1% of the
human proteome [32,33]. The function of these domains remains
unclear, however RNA- and DNA-binding proteins are enriched
among human polypeptides containing putative PFD [32]. The
Fus, TPD-43, hnRNPA1 and hnRNPA2/B1 ribonucleoproteins,
all linked to neurodegenerative disorders, are included in this
group. Despite the scoring of hnRNPA1 and hnRNPA2 fall below
the cut-off for prion identification in yeast sequences using
pWALTZ and also in composition based algorithms like PAPA,
it has been recently reported that discrete missense mutations in
the PFD of hnRNPA1 (D262V and D262N) and hnRNPA2
(D290V) cause multisystem proteinopathy and amyotrophic lateral
sclerosis [34]. Importantly, these residues are located at the
highest-scoring 21 residues window as identified by pWALTZ for
both hnRNPA1 (G247-N267) and hnRNPA2 (Y275-N295) PFDs
and all the pathogenic mutations increase the pWALTZ value
(Table 3), suggesting that increased amyloidogenicity might
account for the accumulation as cytoplasmic inclusions of the
mutated species in animal models [34]. This suggestion is in line
with the highest in vitro aggregation propensity of the disease-
linked variants and the highest amyloid propensity of hexapeptides
including the mutated residues, relative to those of the wild type
sequences [34]. Moreover, hnRNPA2 and hnRNPA1 variants
lacking the 287–292 and 259–264 sequence stretches, respectively,
both inside the pWALTZ best scoring windows for the wild type
proteins (Table 2), are aggregation resistant, even in the presence
Fig. 1. Prediction of prion propensity of Q/N-rich putative
prions. Prion recovery using the prion/non-prion (NP/P) classification
of selected putative prions according to Alberti’s scale of prion activity.
ROC plots shows pWALTZ (A) and PAPA (B) performance and box plots
showing predicted prion propensity as scored by pWALTZ (C) and PAPA
(D) are shown.
doi:10.1371/journal.pcbi.1004013.g001
Fig. 2. Relationship between amyloid and prion propensities.
Average pWALTZ scores of prion (white) and non-prion (red) domains.
doi:10.1371/journal.pcbi.1004013.g002
Prediction of Prion Proteins
PLOS Computational Biology | www.ploscompbiol.org 4 January 2015 | Volume 11 | Issue 1 | e1004013
of preformed homologous wild type or mutant amyloid fibrils [34].
Accordingly, the new high scoring sequences in this deleted PFDs
display significantly lower pWALTZ values than those in their
respective wild type sequences (Table 3). Despite their aggregation
properties, it cannot be affirmed that hnRNPA1 and hnRNPA2 or
their mutants constitute bona fide prions in humans, since their
propagation has yet not been demonstrated. Nevertheless, this
property can be approximated exploiting the modular nature of
yeast prion proteins. Kim and co-workers replaced the Sup35
nucleation domain with the core PFD from either hnRNPA2 or
the D290V mutant and expressed these fusions as the unique
copies of Sup35 in yeast cells. In agreement with its classification
as a prion domain according to pWALTZ (Table 3), only the
mutant variant can substitute for the Sup35 nucleation domain in
supporting prion formation and specifically promoting the
nucleation activity [34].
A reason for the accuracy of the pWALTZ can be found
inspecting the values for Q and N in the position specific scoring
matrix (PSSM) behind Waltz: N is favourable for amyloid
formation in all hexapeptide positions except position 5, and Q
is favourable in all positions except 4 and 5 [16]. Therefore a
sequence stretch with high Q/N content, in which position 4 is an
N and position 5 is an amyloid-promoting residue, will have a
strong amyloid forming potential. As position 5 is the most
restrictive position in the Waltz PSSM, that leaves Ile, Phe and
Tyr as the main options, of which the latter is a residue that occurs
with high frequency in prion sequences. These considerations
suggest that low complexity sequences biased towards Q and N
might display an intrinsic propensity to accommodate one or more
amyloid cores. However, because the amyloid propensity of Q and
N is generally lower than the one of hydrophobic residues it is
conceivable that, in order to nucleate the self-assembly reaction
the amyloid cores in Q/N rich sequences should involve more
residues than in typical amyloids were they tend to be very short
and typically highly enriched in hydrophobic residues [12]. This
would explain why predictions aimed to identify these very short
and highly potent protein segments fail to classify correctly Q/N
based prionic sequences [15] and why pure polyQ sequences
require very large stretches to attain amyloidogenic potential [35].
The relationship between aggregation and structural
order in prion proteins
A surprising finding in Alberti’s study is that, despite differing
only in a methylene group, the ratio of N to Q residues is an
important determinant of the prion propensity of a sequence.
Prionic domains are, as a trend, enriched in N whereas Q are
more abundant in non-prionic sequences in their dataset [15].
Since according to our analysis amyloidogenicity seems to
contribute significantly to prion-forming capability, it could be
simply that N residues are more amyloidogenic than Q in the
context of prion sequences, in agreement with the observation that
according to the WALTZ PSSM, N is tolerated in more positions
than Q in amyloid sequences (S1 Fig). Interestingly, the 21
residues long amyloid cores detected by pWALTZ in prionic
sequences in our dataset contain an average of 9.9 N and 1.3 Q
residues, whereas the equivalent sequence stretches in non-prionic
Table 2. Prediction of the prionic behaviour of synthetic yeast prions.
Gene Name pWALTZ window pWALTZ Score
s-PFD1 NGEQSFWYQQNNNLQQQGNYQ 74.73
s-PFD2 QNQNGYYNNQNQIQQAQQNTQ 74.36
c-PFD1 LAMNQHTKLNNENNSQDFLQQ 65.44
c-PFD2 QMNKRYNKKYSSNHTQQTSNH 66.73
c-PFD3 AGQALQHQNHKRYENNQAWEQ 66.30
Synthetic PFDs (s-PFD) exhibiting prion behaviour in yeast and negative control sequences (c-PFD), as designed by Toombs et al. [15], where analysed with pWALTZ.
Sequences with pWALTZ score .73.55 are considered prion-like. Predicted prion and non-prion sequences are shown in bold and plain text, respectively.
doi:10.1371/journal.pcbi.1004013.t002
Table 3. Amyloidogenic regions in the PFDs of hnRNPA1 and hnRNPA2.
Gene Name pWALTZ window pWALTZ Score
hnRNPA1 247-GFGNDGSNFGGGSYNDFGNYN-267 68.48
D262V 247-GFGNDGSNFGGGSYNVFGNYN-267 71.82
D262N 247-GFGNDGSNFGGGSYNNFGNYN-267 71.32
D259-264(a) 241-SGDGYNGFGNDGSNFGGGNYN-267 65.56
hnRNPA2 275-YDNYGGGNYGSGNYNDFGNYN-295 71.82
D290V(b) 275-YDNYGGGNYGSGNYNVFGNYN-295 75.03
D287-292 (a) 271-YGGGYDNYGGGNYGSGNYNQQ-297 64.66
The highest pWALTZ scoring windows and the pWALTZ values for these sequences are shown for the wild type, pathogenic and deleted variants of the proteins.
Positions in which natural mutations occur are shown in bold, deleted regions in D mutants are underlined.
(a)Variants with reduced amyloid propensity relative to the wild type sequence.
(b)Variants that can substitute for the Sup35 nucleation domain in supporting prion formation and promote the nucleation activity in yeast.
doi:10.1371/journal.pcbi.1004013.t003
Prediction of Prion Proteins
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sequences contain 4.1 N and 6.0 Q residues, respectively.
Therefore, despite in both cases Q+N account for ,1/2 of the
residues in the core, amyloid cores in prionic domains are highly
enriched in N residues, with a N/Q ratio of 7.9, whereas non-
prionic cores display a N/Q ratio of only 0.7 at their cores. This
suggests that despite their similar physicochemical properties these
two residues endorse sequences with different amyloidogenic
potential. Consistently, when we compared the predicted amyloi-
dogenicity of known yeast PFD and of virtual mutants in which all
N were replaced by Q and vice versa using pWALTZ, we found
that, as a trend, the N to Q replacement decreases the amyloid
propensity of the domains, whereas changing Q into N results in
propensities similar that of the wild type sequence, when the core
is already enriched in N residues, or increases the amyloid
propensity of the domain (Fig. 3). These observations are in
excellent agreement with the recent experimental demonstration
by the Lindquist’s group that N richness promotes assembly of self-
templating amyloids whereas Q richness favours the formation of
non-amyloid conformers [36].
The intriguing question thus remains of why PFDs are enriched in
Q and especially in N and not in other residues with a higher
hydrophobicity and/or b-sheet propensity, which would render them
more amyloidogenic, as in typical amyloids. Together with their high
Q/N content and their ability to form amyloid assemblies, an
essential property of yeast PFD is that they lack regular secondary
structure in their soluble state. It could be simply that Q and
especially N constitute the most amyloidogenic residues that are still
able to promote significant intrinsic disorder in a protein sequence.
Not surprisingly, according to the FoldIndex algorithm [37] all the
detected amyloid cores in prion domains are located in disordered
protein regions. To test this possibility we constructed 21-mer homo-
polymeric sequences for the 20 natural amino acids and analyzed
their disorder and amyloidogenic propensity using Foldindex and
pWALTZ simultaneously (Fig. 4). Interestingly enough, polyQ and
specially polyN display both a high disorder and amyloidogenic
propensity. Thus, Q and N enriched sequences would have a dual
character that would allow them to maintain a certain amyloid
potential and still remain disordered. However, polyQ and polyN
render pWALTZ scores of 49.83 and 70.90, respectively, thus
indicating that 21 residues core formed exclusively by these residues
would not endorse prioneginicty to a sequence and therefore that the
presence of hydrophobic residues in the core is a requirement for
prion formation. The rest of predicted disordered sequences do not
exhibit any amyloidogenic propensity according to pWALTZ, with
the exception of polyY. Tyrosine is the most abundant hydrophobic
residue in yeast PFDs [8]. We compared the composition of
hydrophobic residues in the amyloid cores detected by pWALTZ
in prionic and non-prionic sequences (Fig. 5) and found that non-
aromatic hydrophobic residues are strongly underrepresented in both
cores, relative to their average frequency in Swissprot [38], whereas
aromatic residues are overrepresented in prionic cores and under-
represented in non-prionic ones, respectively. However, Tyr is the
only residue that contributes to the overrepresentation of aromatic
residues in prionic amyloid cores, being 2.7 times more abundant that
the average in Swissprot (Fig. 5). It has been recently proposed that
aromatic residues are favoured in PFD relative to non-aromatic
hydrophobic residues, because they serve a dual function, promoting
both prion formation and chaperone dependent prion propagation
[39]. However, this does not explain why, despite differing in a single
hydroxyl group, Tyr is much more prevalent than Phe at both the
PFDs and their amyloid cores. A plausible reason for this bias is that
Tyr displays a clearly higher amyloidogenicity/disorder ratio than
Phe and the rest of hydrophobic residues, followed by Trp, which due
to its size might cause steric hindrance in prion fibrillar structures,
explaining its low abundance in PFDs [8]. Additionally, from the best
scoring residues in the restrictive position 5 in the Waltz PSSM, Tyr is
clearly superior in terms of disorder propensity, appearing thus as the
best residue to endorse prionogenic Q/N rich amyloid cores with
increased amyloid potential without disturbing significantly the PFDs
disorder properties.
Long disordered regions in functional intrinsically disordered
proteins (IDPs) are significantly depleted in N, whereas they are,
for instance, enriched in Q or S residues [40]. No satisfactory
explanation for this low representation of N residues in intrinsi-
cally disordered regions has been provided yet. Our analysis
suggests that because, in contrast to prions, IDPs need to remain
soluble during all their existence in the cell, the reduction in the
proportion of N residues might respond to an evolutionary strategy
to avoid the spontaneous self-assembly. The same reason might
explain why the occurrence of homo-polymeric amino acid
stretches of 20 or more Q in proteomes is four times higher than
that of N repeats despite the abundance of these residues in the
corresponding proteins is fairly similar (4.4 and 3.9% for N and Q,
respectively) [41]. This may be especially true because mutation of
one of several of the N residues in an N repeat into an
hydrophobic residue might lead to the formation of a strong
enough amyloid core to induce the protein aggregation.
The intermediate amyloid potential of N might be important for
prion propagation. It has been shown that the yeast chaperone
Hsp104 promotes prion propagation at intermediate concentra-
tion and that propagation can be blocked by both increasing as
well as decreasing the level of this essential chaperone [42]. This is
rationalised mechanistically by considering the balance between
nucleation and growth of prion amyloids: when the chaperone
breaks up amyloids without fully clearing them, the effective
concentration of seeds is increasing. Fragmentation of fibrils has
Fig. 3. Amyloid propensities of Q and N residues in the context
natural yeast prions. pWALTZ scores of wild-type (WT) (pink) and
virtual mutants in which all Q residues are changed to N (red) or all N
residues into Q (white) in the PrD of natural yeast prions.
doi:10.1371/journal.pcbi.1004013.g003
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also been shown to determine the phenotype strength of different
prion strains, as increased brittleness of fibrils results in a higher
number of independently elongating fibril particles, increasing
thus the efficiency of prion infection [43]. The presence of a strong
and rigid amyloid core formed by a high proportion of highly
amyloidogenic residues would reduce the fragmentation rate and
accordingly, would decrease the prion propagation efficiency. In
this context, N is likely the residue that provides the best balance
between amyloid and propagation potentials.
Discussion
The results in the present study together with several lines of
evidence from the literature indicate that for a protein sequence to
become a prion domain it requires: i) a specific region with significant
amyloid propensity able to selectively nucleate the self-assembly into
ordered, but brittle, amyloid structures ii) a disordered structural
context that, in contrast to what happens in structured globular
proteins, readily permits the domain self-assembly without a
requirement for conformational unfolding, and iii) an amino acid
composition that while allowing the domain to be soluble at the
physiological concentrations required for the normal protein function
still display a basal amyloid propensity, to which N residues would
contribute significantly, promoting their self assembly in the presence
of preformed amyloid seeds or when its concentration is increased. All
these prion properties are readily predictable, opening an avenue for
the accurate identification of prionic sequences in proteomes.
Moreover, because aggregation of human PFD containing proteins
might contribute to the etiology of a number of degenerative diseases,
the present approach might find application in the detection of
pathogenic genetic mutations associated with these disorders.
Composition based methods provide good prion prediction accura-
cies by assuming that in these particular proteins amyloid formation
relies on the establishment a large number of weak interactions
between side-chains in long disordered domains (Fig. 6), but in fact
they mask the presence of specific short sequence stretches that, as in
other amyloids, would trigger the conversion of prions from the
soluble to the aggregated and transmissible state (Fig. 6). Instead of
two contrasting views, our analysis suggests a model for Q/N rich
prions, where a classical amyloid core is embedded in a compositional
context that reduces the amyloid nucleation potential, giving rise to
sequences that are strongly dependent on seeding.
Materials and Methods
Selection of putative prion sequences
From the 100 candidates putative PFD sequences in Alberti’s
data set [8] only those candidates for whom all four experimental
assays could be carried out were selected for further analysis,
accounting a total of 83 sequences.
Classification of prion and non-prion sequences
We used the combined accumulative score reported by Alberti
et al [8]. For the formation of intracellular aggregates and Sup35
switching behavior, the putative prion sequences positive or
negative proteins received 2 and 0 points, respectively. For SDD-
AGE (48 hours of induction) and in vitro assembly assays, the
candidates received points according the resulting scale: - = 0
points, + =1 point, ++ =2 points, +++ =3 points. Therefore, the
maximum combined score is: 2+2+3+3= 10 [8]. Sequences
scoring #2 and being positive in one assay at maximum were
considered as non-prions and sequences being positive in all four
assays and scoring $9 as prions (Table 1). SUP35 was not
included in the test set to avoid overlap with the WALTZ training
set.
Sequence analysis with WALTZ
The Waltz prediction method described in Maurer-Stroh et al
[16] is available at http://waltz.switchlab.org/. The algorithm
allows selecting a custom threshold for sequence analysis. Low
thresholds are useful to determine the aggregation propensity of
sequences without position-specificity restrictions whereas high
thresholds select sequences fulfilling the position-specific require-
ments for amyloid formation. In order to identify the more
Fig. 4. Relationship between amyloid and disorder propensi-
ties of natural amino acids. Ordered and disordered-promoting
homo-polymeric amino acid stretches according to FoldIndex are
represented as triangles and squares, respectively, and sequences with
low, medium and high amyloid propensity as predicted by WALTZ are
represented in green, orange and red, respectively.
doi:10.1371/journal.pcbi.1004013.g004
Fig. 5. Hydrophobic residues in pWALTZ amyloid cores. The
frequency of the indicated hydrophobic residues in pWALTZ amyloid
cores relative to that in all the proteins in SwissProt is plotted for non-
prion (red) and prion (white) domains. Positive and negative values
correspond to overrepresented and underrepresented amino acids or
amino acid groups, respectively.
doi:10.1371/journal.pcbi.1004013.g005
Prediction of Prion Proteins
PLOS Computational Biology | www.ploscompbiol.org 7 January 2015 | Volume 11 | Issue 1 | e1004013
predictive threshold, receiver-operating characteristic (ROC) anal-
ysis of the WALTZ scores for the complete PFD sequences were
obtained using thresholds ranging from 0 to 100%. The ROC curve
is a graphical plot displaying the performance of a binary classifier
system as its discrimination threshold is varied. It plots the fraction
of true positives out of the total actual positives (sensitivity) vs. the
fraction of false positives out of the total actual negatives (specificity),
at various thresholds. The area under the curve (AUC) reflected the
accuracy of the discrimination [44] and therefore the best balance
between position-specific and non-specific aggregation prediction.
The AUC estimates the statistical significance of the classification
test and represents the probability that when a pair of positive and
negative sequences is randomly selected from the pool, the WALTZ
score will be higher for the positive one. The Youden’s J statistic (J),
also called Youden’s index, a single statistic was used to capture the
performance of the diagnostic test since it both measures the
effectiveness of a diagnostic marker and enables the selection of an
optimal cut off point for the marker, which corresponds to the best
combination of sensitivity and specificity in the prediction (J=
Sensitivity + Specificity 21) [45]. The average accuracy was
calculated as: Accuracy = (number of True Positives + number of
True Negatives)/number of elements in the Total Population, for
any given prediction. A pWALTZ executable file, sequence
examples and use instructions can be freely downloaded for
academic use at http://bioinf.uab.es/pWALTZ/. The order/
disorder context of the detected amyloid cores was analyzed with
FoldIndex [38] using the default 51-aa window size along the
complete PFDs.
Supporting Information
S1 Fig Amino acid preferences in the WALTZ scoring
matrix. Residues log-odd scores for amyloid core formation in a
given hexapeptide position.
(TIFF)
S2 Fig Example of pWALTZ procedure for scoring prion
and non-prion sequences. The putative PFDs of ENT2, MCM1
and SWI1, scoring 0, 0 and 9, respectively, according to Alberti et. al.
scale of prion propensity (Cell 2009 137, 146–158) are analysed. In
agreement with experiments, ENT2 (below the threshold) and
MCM1 (pWALTZ score =59.63) are predicted as non-prions and
SWI1 (pWALTZ score =75.43) as containing a prion domain.
(TIFF)
S1 Table Amyloid prediction of sequential variants in the
39 to 46 positions of the Sup35–27 PFD. PSI+ and PSI-
correspond to 8 residues stretches able to support or not prion
conversion when substituting the original sequence in the Sup35–27
variant, respectively. As described by as Toombs and co-workers (Mol
Cell Biol. 2010 30(1): 319–32). Sequences predicted to be amyloido-
genic by WALTZ using the default parameters are shown in bold.
(PDF)
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Fig. 6. Alternative models for amyloid formation in prion-like domains. The compositional model relies on the establishment a large
number of weak interactions whereas the pWALTZ model suggests a preferential nucleation by a short amyloidogenic stretch, whose amyloid
propensity is modulated by the structural context.
doi:10.1371/journal.pcbi.1004013.g006
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